Predictive Oncology Price to Sales Ratio 2010-2024 | POAI
Historical PS ratio values for Predictive Oncology (POAI) over the last 10 years. The current P/S ratio for Predictive Oncology as of February 07, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Predictive Oncology P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-02-07 | 1.45 | 4.68 | |
| 2024-09-30 | 0.79 | $0.31 | 2.54 |
| 2024-06-30 | 1.04 | $0.42 | 2.45 |
| 2024-03-31 | 2.55 | $0.49 | 5.24 |
| 2023-12-31 | 3.29 | $0.44 | 7.41 |
| 2023-09-30 | 3.20 | $0.45 | 7.12 |
| 2023-06-30 | 4.86 | $0.40 | 12.21 |
| 2023-03-31 | 6.54 | $0.38 | 17.25 |
| 2022-12-31 | 6.13 | $0.41 | 14.81 |
| 2022-09-30 | 7.20 | $0.49 | 14.72 |
| 2022-06-30 | 8.20 | $0.47 | 17.50 |
| 2022-03-31 | 19.54 | $0.50 | 39.01 |
| 2021-12-31 | 19.04 | $0.56 | 34.06 |
| 2021-09-30 | 26.60 | $0.88 | 30.33 |
| 2021-06-30 | 26.20 | $1.42 | 18.44 |
| 2021-03-31 | 24.20 | $1.66 | 14.61 |
| 2020-12-31 | 14.65 | $2.72 | 5.39 |
| 2020-09-30 | 16.28 | $4.65 | 3.51 |
| 2020-06-30 | 32.80 | $7.33 | 4.48 |
| 2020-03-31 | 31.51 | $7.91 | 3.98 |
| 2019-12-31 | 52.20 | $9.94 | 5.25 |
| 2019-09-30 | 101.00 | $12.38 | 8.16 |
| 2019-06-30 | 149.50 | $14.03 | 10.66 |
| 2019-03-31 | 150.00 | $19.12 | 7.85 |
| 2018-12-31 | 123.82 | $23.11 | 5.36 |
| 2018-09-30 | 212.00 | $25.17 | 8.42 |
| 2018-06-30 | 226.00 | $25.09 | 9.01 |
| 2018-03-31 | 220.00 | $22.52 | 9.77 |
| 2017-12-31 | 202.00 | $20.71 | 9.76 |
| 2017-09-30 | 290.72 | $23.68 | 12.28 |
| 2017-06-30 | 294.00 | $26.90 | 10.93 |
| 2017-03-31 | 420.00 | $29.76 | 14.11 |
| 2016-12-31 | 560.00 | $51.25 | 10.93 |
| 2016-09-30 | 825.00 | $270.48 | 3.05 |
| 2016-06-30 | 762.50 | $369.62 | 2.06 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.872B | 57.28 |
| Tempus AI (TEM) | United States | $10.232B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.842B | 224.83 |
| Inspire Medical Systems (INSP) | United States | $5.430B | 169.35 |
| IRhythm Technologies (IRTC) | United States | $3.397B | 0.00 |
| Privia Health (PRVA) | United States | $2.723B | 226.90 |
| Enovis (ENOV) | United States | $2.544B | 16.95 |
| Azenta (AZTA) | United States | $2.469B | 114.98 |
| Clover Health Investments (CLOV) | United States | $2.225B | 0.00 |
| Schrodinger (SDGR) | United States | $1.886B | 0.00 |
| Omnicell (OMCL) | United States | $1.826B | 39.83 |
| 10x Genomics (TXG) | United States | $1.773B | 0.00 |
| Phreesia (PHR) | United States | $1.680B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.937B | 0.00 |
| Talkspace (TALK) | United States | $0.608B | 0.00 |
| Standard BioTools (LAB) | United States | $0.529B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.507B | 0.00 |
| TruBridge (TBRG) | United States | $0.380B | 110.57 |
| Nyxoah SA (NYXH) | Belgium | $0.369B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| American Well (AMWL) | United States | $0.176B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.104B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.073B | 0.00 |
| CareCloud (CCLD) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |